Kevin Rubenstein

6PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical virologyImplementation science and evaluationComputer vision
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 22, 2026
Antibiotic Prescribing Practices During the COVID-19 Pandemic: A Post-Hoc Analysis of the Adaptive COVID-19 Treatment Trial.

|Jun 11, 2025
Futility Monitoring in Clinical Trials.

Ana M Ortega-Villa, Megan C Grieco, Kevin Rubenstein

|Apr 16, 2025
Tecovirimat for Clade I MPXV Infection in the Democratic Republic of Congo.

Rosine Ali, Jules Alonga, Jean-Luc Biampata

|Nov 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial.

Gail E Potter, Tyler Bonnett, Kevin Rubenstein

|Sep 15, 2022
Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE).

Irini Sereti, Kathryn Shaw-Saliba, Lori E Dodd

|Mar 02, 2021
Antecedent treat-and-release diagnoses prior to sepsis hospitalization among adult emergency department patients: a look-back analysis employing insurance claims data using Symptom-Disease Pair Analysis of Diagnostic Error (SPADE) methodology.

Najlla Nassery, Michael A Horberg, Kevin B Rubenstein

Pageof 1

Frequent Collaborators

2 joint publications

Gail E Potter

1 joint publications

Najlla Nassery

1 joint publications

Michael A Horberg

1 joint publications

Julia M Certa